December 2024 FDA Recall Timolol Maleate by Fdc Limited
D-0114-2025 - Defective Container

This Class II drug recall was voluntarily initiated by Fdc Limited on December 5, 2024 for the product Timolol Maleate. The FDA reported the reason for recall as defective container. The product was distributed in Distributed to one Us Distributor in NJ. and the recall is currently ongoing.

Recall Number: D-0114-2025

Reason for Recall
Defective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.
Initiated
12-05-2024
Reported
12-18-2024
Quantity
5184 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Distributed to one Us Distributor in NJ.
Timolol Maleate Ophthalmic Solution USP, 0.25%, Sterile, 15mL bottles, Rx only, Manufactured by: FDC Limited, Waluj, Aurangabad, Maharashtra, India, Distributed by: Rising Pharmaceuticals Inc, New Jersey, NDC 64980-513-15.

Batch or Lot Expiration Information

Lot# : 083I006, Exp 08/31/2025